The development of COVID-19 treatment

被引:118
|
作者
Yuan, Yongliang [1 ]
Jiao, Baihai [2 ]
Qu, Lili [3 ]
Yang, Duomeng [3 ]
Liu, Ruijuan [1 ]
机构
[1] Zhengzhou Univ, Dept Pharm, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Univ Connecticut, Sch Med, Dept Med, Div Nephrol,Hlth Ctr, Farmington, CT USA
[3] Univ Connecticut, Sch Med, Dept Immunol, Hlth Ctr, Farmington, CT 06269 USA
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
COVID-19; treatments; antiviral agents; neutralizing antibody therapy; Janus kinase inhibitors; JAK-STAT PATHWAY; OPEN-LABEL; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; RUXOLITINIB; STANDARD; MULTICENTER; FAVIPIRAVIR; TOFACITINIB; COMBINATION;
D O I
10.3389/fimmu.2023.1125246
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest worldwide public health threat of this century. Recent studies have unraveled numerous mysteries of SARS-CoV-2 pathogenesis and thus largely improved the studies of COVID-19 vaccines and therapeutic strategies. However, important questions remain regarding its therapy. In this review, the recent research advances on COVID-19 mechanism are quickly summarized. We mainly discuss current therapy strategies for COVID-19, with an emphasis on antiviral agents, neutralizing antibody therapies, Janus kinase inhibitors, and steroids. When necessary, specific mechanisms and the history of therapy are present, and representative strategies are described in detail. Finally, we discuss key outstanding questions regarding future directions of the development of COVID-19 treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Hydroxychloroquine in the COVID-19 treatment
    Santiesteban Vazquez, Viana Elina
    Castro Barberena, Adys
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2021, 19 (06): : 898 - 899
  • [22] Phytochemicals for the treatment of COVID-19
    Espano, Erica
    Kim, Jiyeon
    Lee, Kiho
    Kim, Jeong-Ki
    JOURNAL OF MICROBIOLOGY, 2021, 59 (11) : 959 - 977
  • [23] Experimental treatment in COVID-19
    Brantsaeter, Arne Broch
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2020, 140 (12) : 1211 - 1211
  • [24] Paxlovid for Treatment of COVID-19
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1642): : 9 - 10
  • [25] Corticosteroids treatment for COVID-19
    Salinas, Mauricio
    REVISTA MEDICA DE CHILE, 2020, 148 (07) : 893 - 894
  • [26] Antibiotics for the treatment of COVID-19
    Popp, Maria
    Stegemann, Miriam
    Riemer, Manuel
    Metzendorf, Maria-Inti
    Romero, Carolina S.
    Mikolajewska, Agata
    Kranke, Peter
    Meybohm, Patrick
    Skoetz, Nicole
    Weibel, Stephanie
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (10):
  • [27] Molnupiravir for the treatment of COVID-19
    Santani, Bela G.
    LeBlanc, Brian W.
    Thakare, Ritesh P.
    DRUGS OF TODAY, 2022, 58 (07) : 335 - 350
  • [28] Cancer treatment and covid-19
    Brustugun, Odd Terje
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2020, 140 (07) : 622 - 622
  • [29] Statin Treatment of COVID-19
    Fedson, David S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 136 : 171 - 173
  • [30] Dexamethasone as a Treatment of COVID-19
    Abdullah Alkattan
    Mahmoud Kandeel
    Dr. Sulaiman Al Habib Medical Journal, 2021, 3 (1) : 7 - 9